Beta-Hydroxybutyrate Feasibility Treating IBD
Recruiting
Phase 1
Phase 2
Interventional Study
Crohn's Disease
Inflammatory Bowel Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 20 (estimated)
- Sponsor
- University of Texas at Austin · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This clinical trial aims to understand the feasibility of patients taking ketone body supplement beta-hydroxybutyrate (BHB) for 4 weeks with a confirmed diagnosis of Crohn's disease and starting new therapy for active disease.
The main questions it aims to answer are:
* BHB supplementation will be feasible and acceptable to patients.
* BHB supplementation will be associated with a reduction in s…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years of age
* Confirmed diagnosis of Crohn's disease
* Active disease defined as either a fecal calprotectin \>250 µg/g or active disease on endoscopy within the prior 3 months
* Starting a new therapy defined as a biologic (anti-TNF, anti-integrin, IL-12/2…
Contacts